DRI's LongHorn Shines With 7.2% Comps: Can This Lead Growth?

DRI's LongHorn Steakhouse posts 7.2% comps, beating industry trends with strong traffic, value appeal and execution, positioning it as a key growth driver.

Zacks Investment Research • Apr 23, 2026

Can AI and Forecasting Tools Boost Darden's Restaurant Efficiency?

DRI taps AI and forecasting tools to sharpen restaurant efficiency, boosting labor planning, reducing waste and improving service without replacing workers.

Zacks Investment Research • Apr 15, 2026

3 Steady Stocks with 3% Yields and Growing Profits

AT&T, Darden Restaurants, and Philip Morris International offer reliable dividends above 3% and steady earnings growth in a volatile market.

Barrons • Apr 14, 2026

Should Investors Be Drawn to the Cheap Valuation of Darden Stock?

DRI trades at a discount with steady comps growth and solid traffic, but margin pressure and macro uncertainty temper its near-term upside.

Zacks Investment Research • Apr 13, 2026

Beef Inflation Bites Darden: Can Pricing Power Offset Costs?

DRI faces beef-driven cost pressure, but steady sales and a cautious pricing strategy aim to balance margins and customer traffic.

Zacks Investment Research • Apr 9, 2026

Darden's Portfolio Strength: Are All Segments Finally Firing Together?

DRI's multi-brand portfolio shows synchronized growth as all segments post positive comps, boosting revenues, traffic and positioning it ahead of peers.

Zacks Investment Research • Apr 2, 2026

Top Wall Street analysts like these dividend stocks for solid returns

These stocks that pay dividends consistently have the ability to generate long-term capital appreciation.

CNBC • Mar 29, 2026

Darden Restaurants: Reiterate Buy Rating As Demand Outlook Remains Solid

Darden Restaurants (DRI) maintains a buy rating as demand remains resilient and management accelerates new store openings. Q3 saw 6% y/y sales growth, with adjusted same-restaurant sales potentially near 5% absent weather and promotion headwinds. Management raised FY2026 new restaurant guidance and expects further acceleration in FY2027, signaling strong confidence in demand trends.

Seeking Alpha • Mar 26, 2026

Darden Restaurants Gains on Menu Innovation Amid Cost Headwinds

DRI gains on menu innovation and strong sales, but inflation, high costs and weather disruptions continue to pressure margins.

Zacks Investment Research • Mar 23, 2026

GLP-1 drugs are changing how Americans eat. Food companies are racing to catch up

For restaurants and food companies, the increasing adoption of GLP-1 drugs present both an opportunity and a threat to their businesses. About one in every eight U.S. adults is currently taking a GLP-1 drug, like Ozempic or Zepbound, according to the KFF Health Tracking Poll.

CNBC • Mar 21, 2026